Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 18c
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.74), $0.18 worse than the analyst estimate of ($0.56).“Over the last ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)